Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • CV Sciences News

    0,0397 $ +4,61% +0,0018 $
    In : 0,0370 € | 24.04.24 21:25:34 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2ALU7
    ISIN: US1266541028
    US-Symbol: CVSI
    Typ: Aktie

    CV Sciences News

    28.03.24 - PR Newswire
    CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
    CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results PR Newswire
    26.03.24 - PR Newswire
    CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
    CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews PR Newswire
    21.03.24 - PR Newswire
    CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
    CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024 PR Newswire
    12.12.23 - PR Newswire
    CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
    CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-​Based Food Market, Opening Door For European Distribution PR Newswire
    14.11.23 - PR Newswire
    CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
    CV Sciences, Inc. Reports Third Quarter 2023 Financial Results PR Newswire
    09.11.23 - PR Newswire
    CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
    CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023 PR Newswire
    05.09.23 - PR Newswire
    CV Sciences, Inc. Launches Reserve Sleep Gummies
    CV Sciences, Inc. Launches Reserve Sleep Gummies PR Newswire
    14.08.23 - PR Newswire
    CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
    CV Sciences, Inc. Reports Second Quarter 2023 Financial Results PR Newswire
    01.08.23 - PR Newswire
    CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
    CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023 PR Newswire
    01.06.23 - PR Newswire
    CV Sciences to Participate in LD Micro Invitational Conference
    CV Sciences to Participate in LD Micro Invitational Conference PR Newswire
    15.05.23 - PR Newswire
    CV Sciences, Inc. Reports First Quarter 2023 Financial Results
    CV Sciences, Inc. Reports First Quarter 2023 Financial Results PR Newswire
    09.05.23 - PR Newswire
    CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023
    CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023 PR Newswire
    03.04.23 - PR Newswire
    CV Sciences, Inc. Introduces New THC Offering
    CV Sciences, Inc. Introduces New THC Offering PR Newswire
    29.03.23 - PR Newswire
    CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results
    CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results PR Newswire
    24.03.23 - PR Newswire
    CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023
    CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023 PR Newswire
    23.03.23 - PR Newswire
    CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction
    CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco ...
    21.03.23 - PR Newswire
    CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels
    CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels PR Newswire
    02.03.23 - PR Newswire
    CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation
    CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation PR Newswire
    19.01.23 - PR Newswire
    CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels
    CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels PR Newswire
    18.01.23 - PR Newswire
    CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels
    CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels PR Newswire

    Newssuche

    Videos

    newspaper
    09:30 Uhr +23,58%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »